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Kirromycin is a complex linear polyketide that acts as
a protein biosynthesis inhibitor by binding to the bac-
terial elongation factor Tu. The kirromycin biosyn-
thetic gene cluster was isolated from the producer,
Streptomyces collinus Tu¨ 365, and confirmed by
targeted disruption of essential biosynthesis genes.
Kirromycin is synthesized by a large hybrid polyke-
tide synthase (PKS)/nonribosomal peptide synthe-
tase (NRPS) encoded by the genes kirAI–kirAVI.
This complex involves some very unusual features,
including the absence of internal acyltransferase
(AT) domains in KirAI-KirAV, multiple split-ups of
PKS modules on separate genes, and swapping in
the domain organization. Interestingly, one PKS en-
zyme, KirAVI, contains internal AT domains. Based
on in silico analysis, a route to pyridone formation in-
volving PKS and NRPS steps was postulated. This
hypothesis was experimentally proven by feeding
studies with [U-13C3
15N]b-alanine and NMR and MS
analyses of the isolated pure kirromycin.
INTRODUCTION
Wolf and Za¨hner (1972) first isolated kirromycin from the actino-
mycete, Streptomyces collinus Tu¨ 365, in a screening program
for narrow-spectrum antibiotics. Around that time, Vos and Ver-
wiel isolated a compound named mocimycin, which is identical
to kirromycin (delvomycin, demethylaurodox) (Vos and Verwiel,
1973; Maehr et al., 1973). Other microbial natural products are
structurally related to kirromycin, such as aurodox (Berger
et al., 1973), kirrothricin (Thein-Schranner et al., 1982), efrotomy-
cin (Wax et al., 1976), ganefromycin (Carter et al., 1988), and he-
neicomycin (Zimmerman et al., 1979).
The biological target for kirromycin was elucidated soon af-
ter its discovery. Kirromycin interacts specifically with the bac-
terial elongation factor Tu (EF-Tu) (Wolf et al., 1972; Wolf et al.,
1974; for a comprehensive review, see Parmeggiani and
Swart, 1985), a rare target for antibiotics. Hence, the nameChemistry & Biology 15,elfamycins comprises the group of active kirromycin and its
congeners.
Cocrystallization of aurodox (N-methyl kirromycin) with puri-
fied EF-Tu from Thermus aquaticus revealed that the substance
binds to the interface of domains I and II of the EF-Tu (Vogeley
et al., 2001). This binding results in a protein conformation that
is no longer able to dissociate from the ribosome, which leads
to a stalling of the ribosome. Additionally, kirromycin binding al-
ters many intrinsic properties of its target: an interaction of EF-Tu
with kirromycin results in stimulation of GTPase activity, a de-
creased affinity of the ternary complex to bind aminoacyl-
tRNA, a failure to interact with EF-Tu, an increased nucleotide
exchange rate for GDP, an increased affinity toward GTP, and
the abolishment of EF-Tu phosphorylation (Alexander et al.,
1995). This target makes kirromycin and its derivatives important
tools in protein biosynthesis research as well as interesting can-
didates for drug development.
Previous studies proved that kirromycin has strong activity
against Streptococci and some Enterococci strains, Neisseria
gonorrhoeae and Haemophilus influenzae (Tavecchia et al.,
1996), whereas, for example, the EF-Tu of Staphylococcus au-
reus is intrinsically resistant to the antibiotic (Hall et al., 1989).
This restricted spectrum of antimicrobial activity is different
from many other antibiotics, where clear biases toward gram-
positive or gram-negative bacteria can be observed. Although
there were no toxic effects observed on higher eukaryotic cells
(Schmid et al., 1978), kirromycin is active against blood cultures
of the malaria parasite, Plasmodium falciparum, by interfering
with organelle-based protein biosynthesis. (Clough et al., 1999).
Two main causes are known to account for the narrow sus-
ceptibility range of kirromycin in the tested organisms: mutations
around the kirromycin binding site in EF-Tu gene can lead to pro-
teins that are resistant to the antibiotic, but retain full functionality
in the protein biosynthesis process (e.g., Mesters et al., 1994); in
other cases, it has been suggested that kirromycin and related
compounds cannot permeate into the cells or are exported
before interaction with EF-Tu.
Unexpectedly, S. collinus Tu¨ 365, the kirromycin producer,
and S. ramocissimus, the mocimycin producer, both express
kirromycin-sensitive elongation factors, also during antibiotic
production (Olsthoorn-Tieleman et al., 2007). These strains ap-
parently have unknown resistance mechanisms. On the other175–188, February 2008 ª2008 Elsevier Ltd All rights reserved 175
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Kirromycin Biosynthesis in S. collinus Tu¨ 365Figure 1. Chemical Structure of Kirromycinhand, some producers of kirromycin-type antibiotics, like S. cin-
namoneus, the producer of kirrothricin (Thein-Schranner et al.,
1982), encode elongation factors that are resistant to their prod-
ucts (Olsthoorn-Tieleman et al., 2002).
The kirromycin molecule is a linear polyketide containing three
intramolecular ring systems: the pyridone ring, the central tetra-
hydrofurane moiety, and a sugar-like structure named goldinonic
acid (Figure 1). In feeding studies with the kirromycin-related
compound aurodox (1-N-methyl-kirromycin) from S. goldinensis
with isotope-labeled precursors, acetate was identified as the
main building block of the carbon skeleton. These results indi-
cate that the ethyl group at C-28 is derived from butyrate, the
methyl group at C-8 from propionate, and the N-26 nitrogen
from glycine. The other methyl groups, C-41, C-42, C-43, and
C-46/C-47 originate from S-adenosyl-methionine. The biosyn-
thetic origin of the pyridone ring, however, remained unclear be-
cause none of the provided substrates were incorporated into
this part of the aurodox molecule (Liu et al., 1979).
The chemical structure and the observed acetate incorpora-
tion pattern indicate a polyketide biosynthesis mechanism in-
volving hybrid type I polyketide synthases (PKSs) and nonriboso-
mal peptide synthetases (NRPS). These modular enzymes have
been studied in great detail (McDaniel et al., 2005; Staunton and
Weissman, 2001). Type I PKSs are large, multifunctional mega-
enzymes catalyzing all steps required for polyketide synthesis.
Each module of a classical type I PKS contains at least three
distinct domains. In analogy to fatty acid biosynthesis, an acyl-
transferase (AT) domain loads the extender unit, usually ma-
lonyl-coenzyme A (CoA) or methylmalonyl-CoA, to the phospho-
pantetheinyl group of an acyl carrier protein (ACP) domain. A
ketosynthase (KS) domain then catalyzes the condensation of
the ACP-bound extender unit with the growing polyketide chain.
Optionally, a set of domains (ketoreductase [KR], dehydratase
[DH], and enoylreductase [ER] domains) is present that carries
out reductions and dehydrations, respectively, on the b-keto
group before the next chain elongation cycle takes place. This
biosynthetic principle is observed in many antibiotic biosynthe-
ses.
Hitherto, several variations of this mechanism have been dis-
covered that illustrate the potential for structural diversity among
microbial products. Complex polyketides, like pederin (Piel,
2002), the related compound, onnamide (Piel et al., 2004a),
and bryostatin (Hildebrand et al., 2004), which are produced by
yet-uncultivated bacterial symbionts of insects or marine
sponges, leinamycin (Tang et al., 2004; Cheng et al., 2003), mu-
pirocin (El Sayed et al., 2003), lankacidin (Arakawa et al., 2005),
and some myxobacterial and fungal metabolites (Carvalho et al.,176 Chemistry & Biology 15, 175–188, February 2008 ª2008 Elsevie2005; Simunovic et al., 2006; Kim and Fuerst, 2006), are synthe-
sized by PKSs that lack internal AT domains. In these cases, it is
suggested that the loading of the PKS internal ACP domains is
performed by external AT enzymes, which are present in biosyn-
thetic gene clusters as individual enzymes. This hypothesis has
been experimentally proven for the PKS that produces leinamy-
cin (Cheng et al., 2003). To describe this architecture, the term
‘‘trans-AT PKS’’ has been introduced for enzymes lacking inter-
nal AT domains, whereas ‘‘cis-AT PKS’’ describes the ‘‘classi-
cal’’ AT-containing PKS.
Here we report the isolation, sequencing, and functional char-
acterization of the kirromycin biosynthetic gene cluster, a novel
member of the rare combined cis- and trans-AT PKS family
and the molecular origin of the pyridone group of kirromycin.
RESULTS AND DISCUSSION
Isolation of the Kirromycin Biosynthetic Gene Cluster
A cosmid library of the kirromycin producer, S. collinus Tu¨ 365,
was generated with the cosmid vector, pOJ436 (Bierman et al.,
1992). In total, 2304 clones were transferred into six 384-well
plates and spotted onto hybridization membranes.
The chemical structure of kirromycin suggests a classical type
I polyketide biosynthesis mechanism (PKS I). This knowledge
can be exploited to construct primers for genetic screening (We-
ber et al., 2003). Degenerate primers were deduced from multi-
ple sequence alignments of diverse cis-AT type clusters and
used to label probes by PCR techniques. For the first screening,
probes derived from other known PKS I producers (see Experi-
mental Procedures) were labeled by using the primers KSII-
FOR/ATIREV, and were subsequently pooled. We then gener-
ated a second DNA probe directly from the total DNA of the
kirromycin producer, S. collinus Tu¨ 365, by using the primers
1KS50/2rAT30.
In total, 43 hybridizing colonies were identified with the two
probes. The cosmids were isolated and classified by restriction
mapping (data not shown), resulting in four major families, along
with seven cosmids that did not readily fit into these families.
In order to determine whether genes encoded on these cos-
mids are involved in kirromycin biosynthesis, one member of
each family was subcloned with BamHI into the gene-inactiva-
tion vector, pK18mob/apra, and transferred into S. collinus Tu¨
365 via intergeneric conjugation. Mutant S. collinus 1C24, ob-
tained after integration of p1C24u, which carries a 2.3 kb internal
PKS fragment derived from cosmid 1C24, was no longer able to
produce kirromycin (Figure 2). This result indicates that cosmid
1C24 carries genes of the kirromycin biosynthetic gene cluster.r Ltd All rights reserved
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mid-insert ends, the four overlapping cosmids (6O07, 2C23,
1C24, and 2K05) were identified (Figure 3B).
Figure 2. HPLC/MS Analyses of Mutants
Generated in This Study
(A) HPLC-traces (UV detection at l = 230–246 nm)
of culture extracts of S. collinus Tu¨ 365 wild type,
and mutants 1C24u, kirAVI::thio, orf(1)::thio,
orf(+1)::pTLiNRPS2. Kirromycin (Rt = 16.5 min)
was detected by UV-Vis (data not shown) and
mass spectrometry.
(B) Mass spectrum of kirromycin, recorded in neg-
ative ion mode showing the characteristic m/z =
795 [MH]-Peak.
Proof that the Isolated Genes
Account for Kirromycin
Biosynthesis
To ensure that the identified genes really
encode the kirromycin biosynthesis gene
cluster, a directed gene disruption of the
PKS gene, kirAVI, was performed with
the inactivation plasmid, pA18-kirAVI::-
thio. Among 576 clones that were tested
for double crossover events, one clone
was identified that was thiostrepton re-
sistant and apramycin sensitive, and
showed the correct fragment sizes in
control PCR and Southern hybridization
experiments (data not shown). This clone
was termed S. collinus kirAVI::thio.
In bioassays against S. albus G, and in
HPLC-MS-DAD analyses of extracts
from culture supernatants, no kirromycin
production was detected in this mutant
(Figure 2). The loss of kirromycin produc-
tion in the S. collinus mutants, 1C24 and
kirAVI::thio, proves that the isolated
genes are involved in kirromycin production and that we isolated
the correct cluster.Sequencing of the Kirromycin Biosynthesis
Gene Cluster
Sequencing of the four identified cosmids covering 130 kb of the
kirromycin biosynthesis locus resulted in the identification of 57
open reading frames (ORFs) (Figure 3). The overall GC content of
the sequenced region is 73.7%. Approximately 60 kb code for
eight enzymes related to polyketide biosynthesis. The region
also contains nine genes with similarities to oxidoreductases,
four putative regulatory genes, one methyltransferase gene,
and some genes encoding hypothetical proteins. Surprisingly,
a set of NRPS genes was also identified directly downstream
of the putative kirromycin biosynthetic gene cluster. There are
two DNA regions present in the sequenced region, spanning
1.36 and 1.88 kb, where no coding sequences were identified
by automatic or manual analysis. For a full list of identified genes,
see Table S1 in the Supplemental Data available with this article
online.Chemistry & Biology 15,Determination of the Cluster Boundaries
Apart from genes encoding PKS and typical secondary metabo-
lite-related tailoring enzymes, several NRPS genes were identi-
fied that have no obvious function in kirromycin biosynthesis. Al-
though the involvement of two NRPS modules can be postulated
for the synthesis of the pyridone ring and the aliphatic amide
bond, no distinct function of the remaining NRPS enzymes could
be deduced from a hypothetical biosynthetic pathway. Most of
the NRPS genes (orf(+1), orf(+6)-(+8)) are located in a cluster
that is separated from the rest by a noncoding sequence gap
containing 1881 bp. In order to test whether these peptide syn-
thetases are involved in kirromycin biosynthesis, orf(+1) was dis-
rupted with the inactivation plasmid, pA18-orf(+1), resulting in
mutant orf(+1)::pA18. The integration of this plasmid into the
chromosome, which led to a loss of function of orf(+1), was
proven by Southern hybridization (data not shown). The mutation
did not influence kirromycin production, as the antibiotic was
still detectable by TLC and HPLC analyses of culture extracts
(Figure 2). This indicates that orf(+1) is not involved in the175–188, February 2008 ª2008 Elsevier Ltd All rights reserved 177
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Gene Cluster
(A) Schematic representation of the kirromycin
biosynthesis locus. White: genes putatively not in-
volved in kirromycin biosynthesis; light gray: PKS
and related genes; black: genes involved in tailor-
ing reactions, precursor supply, regulation, trans-
port, and with unknown function. The filled trian-
gles indicate regions > 1 kb where no coding
sequence was identified.
(B) Isolated and sequenced cosmids that overlap
the kirromycin biosynthesis locus.biosynthesis of kirromycin and, therefore, orf(+1) and the other
genes identified in the NRPS region may code for the biosynthe-
sis of a novel, yet unidentified, metabolite.
At the opposite site of the sequenced DNA region, kirP is, to
our knowledge, the first gene for which we can postulate a puta-
tive function in kirromycin biosynthesis. kirP is located directly
upstream from the first PKS gene, kirAI, in an inverse transcrip-
tional orientation. Its gene product, KirP, is highly similar to
Sfp-type phosphopantetheinyl transferases (66% similarity,
56% identity to PptA from the bleomycin producer, S. verticillus).
These enzymes are usually required to attach a phosphopante-
theine prosthetic group to carrier proteins of PKS and NRPS
enzymes (Lambalot et al., 1996). To prove that KirP is involved
in kirromycin biosynthesis, an inactivation plasmid was con-
structed by PCR amplification of the upstream and downstream
DNA regions, followed by cloning into the conjugative vector
pA18 and insertion of a thiostrepton resistance cassette derived
from pSLE61 (Muth et al., 1988). This construct was introduced
into S. collinus, where homologous recombination led to a dis-
ruption of kirP with the thiostrepton resistance gene which
resulted in mutant S. collinus kirP::thio. The inactivation of kirP
resulted in a significantly decreased level of antibiotic production
(data not shown), indicating a role of kirP in kirromycin
biosynthesis.
A similar gene inactivation experiment generated a mutant
orf(1)::thio to test whether the adjacent gene, orf(1), which en-
codes a highly conserved hypothetical protein, is also involved in
the synthesis of kirromycin. The disruption of orf(1) did not in-
fluence kirromycin production (Figure 2). Antibiotic production
was still detectable by HPLC in culture extracts of mutant
orf(1)::thio. As all other upstream genes of orf(1) have no ho-
mology to secondary metabolite biosynthesis genes, orf(1)
marks the upstream border region of the kirromycin biosynthesis
gene cluster.
The results of the inactivation studies on orf(1) and orf(+1) in-
dicate that the kirromycin biosynthetic gene cluster comprises
26 genes spanning approximately 82 kb of DNA (Table 1).
Synthesis of the Kirromycin Backbone
The analysis of the PKS domain structure (Figure 4) indicates that
the biosynthesis starts with the loading of acetyl-CoA to an un-
usual loading module of KirAI. This loading module consists of
an N-terminal 320 aa-spanning domain (XL) without sequence178 Chemistry & Biology 15, 175–188, February 2008 ª2008 Elseviesimilarity to known proteins or conserved protein motifs and
a typical ACP domain. There are a few indications that KirE, a pu-
tative GNAT-family acetyl transferase, might also be involved in
loading the starter unit onto KirAI (see below). A prominent fea-
ture of kirromycin and its derivatives is the presence of a cis-ole-
finic structure at C-37 and C-38. Module 1 of KirAI does not con-
tain a typical DH domain. Instead, the domain termed X1 is
present, which is weakly similar to a domain of unknown function
in module 7 of the macrolactin PKS MlnE of Bacillus amylolique-
faciens FZB42 (Chen et al., 2007; Schneider et al., 2007) (23%
identity, 38% similarity). Similar to kirromycin, no DH domain is
encoded in this PKS module, but a cis double bond is present
at the corresponding position in the macrolactin molecule.
Thus, it is possible that the X1 domain of KirAI and its homolog
in MlnE are prototypes of novel DH domains catalyzing cis dou-
ble-bond formations.
The polyketide chain is extended by the PKS modules of KirAI
and KirAII, and then condensed with glycine by the hybrid NRPS/
PKS KirAIII, which yields the amide bond and is further extended
by the action of KirAIV-VI. The final step, a condensation of the
kirromycin precursor with b-alanine, is proposed to be catalyzed
by KirB. A thioesterase is neither present as a domain in PKS or
NRPS enzymes, nor present as a separate enzyme in the gene
cluster. This absence implies that the synthesized chain has to
be cleaved, either driven by the pyridone ring formation from
the PKS/NRPS complex or by an external thioesterase, which
is recruited to cut off the product. Either during or after release,
this intermediate has to undergo cyclization and oxidation to
form the pyridone moiety (see below).
Interestingly, only the PKS KirAVI consists of the ‘‘classical’’
PKS domain organization: each of the two modules contains
a KS, an AT, and an ACP domain. Module 14 also contains addi-
tional DH and KR domains. According to the hypothetical path-
way and to the analysis of conserved amino acid positions in
the active sites of the AT domains (Yadav et al., 2003), KirAVI
adds two extender units to the nascent kirromycin precursor:
one methylmalonyl-CoA and one malonyl-CoA, which are
thought to build up a part of the pyridone moiety.
In contrast to the classical ‘‘cis-AT-type’’ organization of Kir-
AVI, AT domains are absent in the other PKS modules. To our
knowledge, kirromycin is the first actinomycete metabolite
shown to be synthesized from combined cis- and trans-AT-
type PKS I enzymes. Similar combinations of PKS types haver Ltd All rights reserved
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Gene
Name aa/nta Putative Function
BLAST Score/
E Value C/Ib Greatest Similarity to: UniProt ID
orf(1) 507/169 Hypothetical protein 269/2e71 85.63/77.84 Streptomyces avermitilis Q82IH7
kirP 756/252 Phosphopantetheinyl
transferase
250/3e65 66.11/56.49 Streptomyces verticillus Q9F0Q6
kirAI 5982/1994 Trans-AT type PKS 1069/0.0 49.27/38.25 Polyangium cellulosum Q2N3S9
kirAII 13152/4384 Trans-AT type PKS 1671/0.0 48.19/34.90 Pseudomonas fluorescens
(strain Pf-5)
Q4KCD7
kirAIII 4653/1551 Hybrid NRPS/PKS 787/0.0 48.88/36.44 Burkholderia pseudomallei Q63LK7
kirAIV 19197/6398 Trans-AT type PKS 1782/0.0 47.78/37.05 Burkholderia thailandensis
(strain E264)
Q2T4P0
kirAV 6861/2287 Trans-AT type PKS 1005/0.0 49.28/37.17 Sorangium cellulosum Q2N3S7
kirAVI 8697/2898 Cis-AT type PKS 2467/0.0 60.36/49.85 Streptomyces halstedii Q0PCZ9
kirHI 849/283 Hypothetical protein 149/9e35 49.63/36.03 Streptomyces aureofaciens Q30CS4
kirB 3102/1034 Nonribosomal peptide
synthase
535/1e150 49.76/37.32 Thermobifida fusca
(strain YX)
Q47NR9
kirCI 3237/1079 Acyltransferase 841/0.0 59.56/44.85 Pseudomonas fluorescens Q8RL73
kirOI 1200/400 Cytochrome P450
hydroxylase
506/1e142 83.93/74.40 Frankia sp. (strain CcI3) Q2JE01
kirD 420/140 Aspartate 1-decarboxylase
precursor
194/8e49 83.82/72.06 Frankia sp. (strain CcI3) Q2JE00
kirM 957/319 Methyltransferase 474/1e132 85.53/73.90 Streptomyces
hygroscopicus
Q54303
kirCII 1338/446 Acyltransferase 341/3e92 60.39/47.19 Stigmatella aurantiaca Q8RJY6
kirHII 558/186 Hypothetical protein 104/1e21 52.63/40.35 Streptomyces coelicolor Q9KYH5
kirHIII 333/111 Hypothetical protein 85.5/5e16 62.39/44.95 Streptomyces coelicolor Q9ZBI3
kirTI 903/301 Major facilitator
superfamily transporter,
C-terminus
261/2e68 76.24/62.38 Frankia sp. (strain CcI3) Q2JDZ4
kirTII 747/249 Major facilitator superfamily
transporter, N-terminus
314/2e84 81.74/66.96 Frankia sp. (strain CcI3) Q2JDZ4
kirRI 315/105 Transcriptional regulatory
protein, TetR family,
C-terminus
107/1e22 75.58/61.63 Frankia sp. (strain CcI3) Q2JDZ6
kirRII 360/120 Transcriptional regulatory
protein, TetR
family, N-terminus
144/1e33 86.27/67.65 Frankia sp. (strain CcI3) Q2JDZ6
kirOII 1218/406 Cytochrome P450
hydroxylase
270/6e71 58.11/41.62 Streptomyces sp. IHS-0435 Q595U8
kirHIV 783/261 Hypothetical protein 267/3e70 67.45/54.12 Frankia sp. EAN1pec Q3VY66
kirHV 396/131 Hypothetical protein 154/1e36 76.27/64.41 Frankia sp. (strain CcI3) Q2JDZ1
kirN 1368/456 Crotonyl CoA reductase 737/0.0 88.26/77.88 Streptomyces collinus Q53865
kirHVI 846/282 Hypothetical protein 263/5e69 67.63/50.00 Burkholderia cepacia (strain
ATCC 17760)
Q39NX9
kirE 510/169 Acetyltransferase, GNAT
family
72.0/8e12 47.83/29.71 Vibrio angustum S14 Q1ZR07
orf(+1) 7392/2463 NRPS 1469/0.0 53.34/38.64 Myxococcus xanthus (strain
DK 1622)
Q1D6B8
a aa, amino acids; nt, nucleotides.
b C, conserved amino acids in BLAST high-scoring sequence pairs; I, identical amino acids in BLAST high-scoring sequence pairs.only been previously described for the biosynthesis of the myx-
obacterial metabolites chivosazol (Perlova et al., 2006) and
myxovirescin A (Simunovic et al., 2006).Chemistry & Biology 15,KirAI–KirAV have an unusual domain order and module orga-
nization. Normally, each PKS module starts with a KS and (in
the case of cis-AT-type PKS) an AT domain, which are then175–188, February 2008 ª2008 Elsevier Ltd All rights reserved 179
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Kirromycin Biosynthesis in S. collinus Tu¨ 365alternatively followed by ER, DH, and KR domains. In most
cases, the end of a module is determined by an ACP domain.
However, the kirromycin PKS modules 2 and 12 show different
organization. Instead of marking the end of the modules, both
ACP domains are located between the DH and KR domains. Ad-
ditionally, the KS domains of modules 2, 7, and 12 are not en-
coded on the same gene, but instead are located at the C termi-
nus of the preceding PKS protein. To date, similar domain
splitting had only been observed in other trans-AT-type PKS
clusters, such as the biosynthetic gene clusters for leinamycin
(Tang et al., 2004), pederin (Piel, 2002), chivosazol (Perlova
et al., 2006), myxovirescin A (Simunovic et al., 2006), or macro-
lactin (Chen et al., 2007). These observations indicate that
trans-AT PKS have more flexibility in their domain organization
than cis-AT PKS.
The two methyl groups at position C-32 and the methyl groups
at C-19 and C-21 are derived from S-adenosyl-methionine and
not from propionate (Liu et al., 1979). This is consistent with
the presence of methyltransferase domains in modules 3 and
8. Module 9 contributes to the incorporation of the C-17/C-19
acetate unit. No methyltransferase domain is present in this
module, although the kirromycin molecule is methylated at the
corresponding carbon C-19. There is no other enzyme with ho-
mology to C-methyltransferases present in the cluster. This ap-
parent absence leads us to postulate that this methylation might
be catalyzed by the methyltransferase domain of module 8 or by
a methyltransferase not encoded in the kirromycin biosynthesis
gene cluster. The KR domains present in the kirromycin cluster
all show the proposed typical KR catalytic triad (Lys-Ser-Tyr, de-
scribed by Reid et al. [2003]). Compared to cis-type PKS I, the
DH domains present in KirAII, KirAIV, and KirAV are shorter
than the DH domains from cis-AT-type PKS clusters. A similar
observation was made in the leinamycin PKS (Tang et al.,
2004). Again, some of the domains show variations in the con-
sensus motif HxxxGxxxxP (according to Aparicio et al., 1996).
Putative Configurations and Ring Closures
of Kirromycin Backbone Formation
The analysis of the central regions of the KR domains facilitates
the prediction of the putative configuration of the resulting alco-
hols, or (with a subsequent action of a DH) of the resulting double
bonds. KRs with the characteristic aspartate residue usually fa-
vor formation of D-configured alcohols (Reid et al., 2003). Corre-
spondingly, additional action of DHs frequently leads to trans
double bonds after ketoreductions (exceptions are known [Per-
lova et al., 2006]). In the case of kirromycin, the sequence data
indeed predict the configurations of alcohols and double bonds
as present in the kirromycin structure (Table S3). However, one
has to consider that late biosynthetic steps, like oxygenations
(C-30, C-16), furan ring formation (C14–C-17), or reduction/
methylation (C-20-OCH3), create new stereogenic centers in
the kirromycin backbone.
Aside from the fully unsaturated pyridone ring, two additional
intramolecular rings are characteristic of kirromycin in respectChemistry & Biology 15,to other elfamycin congeners (for details on their putative biosyn-
thesis see Supplemental Data). Presumably, the sugar-like gold-
inonic acid is formed via acetalization of the C-33 hydroxyl group
(O-34) and the C-29 ketone as the chemically favored, six-mem-
bered pyran ring. While this usually spontaneous ring closure
might already occur in the growing PKS chain (e.g., on module
5 of KirAII), hydroxylation of C-30 is likely accomplished by
post-PKS oxygenation. Furan formation might be triggered by
an initiatory dehydration of the PKS-derived C-15 hydroxyl group
to give the double bond that is presumably epoxidized. Nucleo-
philic epoxide ring opening might furnish the C-14–C-17 furan
ring, which is further oxidized (C-16-OH). However, the kirromy-
cin sequence data do not support the presence of the necessary
enzyme activities, such as DHs, epoxidases, or hydrolases (see
Supplemental Data).
Two External AT Genes Are Encoded in the Kirromycin
Biosynthesis Gene Cluster
kirCI and kirCII are two genes with products that are highly similar
to ATs. They are encoded downstream of the PKS genes; kirCI
encodes a 1078 aa protein, which has greatest similarity to
MmpIII (44% identity, 59% similarity) from the mupirocin biosyn-
thetic gene cluster from Pseudomonas fluorescens (El Sayed
et al., 2003). This enzyme is believed to be responsible for the
loading of the mupirocin PKS, which also lacks internal AT do-
mains. Similar to MmpIII, KirCI contains two AT domains (KirC-
I_AT1 and KirCI_AT2) and an additional domain weakly homolo-
gous to oxidoreductases. While KirCI_AT2 shows a perfect
match to the malonyl-CoA specificity amino acid signature (Ya-
dav et al., 2003), two highly conserved amino acids are ex-
changed in KirCI_AT1. At position 91 (relating to Escherichia
coli FabD amino acid numbering), a highly conserved histidine
residue is replaced by alanine and, at position 117, a conserved
arginine is exchanged for glutamine in KirCI. Interestingly, do-
main 1 of KirCI forms a distinct branch with domain 1 of MmpIII
and PedC (pederin) (Figure S1). KirCI_AT2 clusters within a larger
family containing LnmG (leinamycin) and domain 2 of MmpIII and
PedD. This implies that the functions of PedC and PedD, which
are encoded by two separate enzymes in pederin biosynthesis,
might be provided by a single enzyme (KirCI) in kirromycin bio-
synthesis. In neither case has the specific function of these
domains been experimentally determined.
The second enzyme, KirCII, contains only a single AT domain. In
contrast to the AT domains of KirCI, this domain is a member of the
methylmalonyl-CoA-specific family in phylogenetic analysis. This
is also represented in the high similarity to the ‘‘classical’’ cis-
type AT domain of the PKS StiA from the stigmatellin biosynthetic
gene cluster (Gaitatzis et al., 2002) found in the myxobacterium,
Stigmatella aurantiaca. The particular roles of KirCI and KirCII in
kirromycin biosynthesis are currently under investigation. One
of the ATs may be responsible for the loading of the ACP domains
needed for the extension of the polyketide chain with malonyl-
CoA, whereas the other may catalyze the loading of the single
ethylmalonyl-CoA to the ACP domain of module 5.Figure 4. Hypothetical Kirromycin Biosynthesis Pathway
A: adenylation domain; ACP: acyl carrier protein; AT: acyltransferase domain; C: condensation domain; DH: dehydratase domain ER: enoyl reductase domain;
KR: keto reductase domain; KS: keto synthase domain; MT: methyl transferase domain; PCP: peptidyl carrier protein. X: Domains with unknown function. Mod-
ules that are split on two genes are indicated with a filled circle. KR type A leads to L configuration of the hydroxy group; KR type B leads to D configuration.175–188, February 2008 ª2008 Elsevier Ltd All rights reserved 181
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transferases of the GNAT family (Interpro family: IPR000182).
KirE shares 47% sequence similarity and 32% sequence identity
to an as-yet uncharacterized putative acetyltransferase of Soli-
bacter usitatus Ellin 6076. Notably, a GNAT domain is present
in pederin biosynthesis as the first domain in the pederin PKS
PedI. It is postulated that this domain plays an essential role in
loading the acetyl-CoA starter unit to the ACP of the PKS loading
module (Piel et al., 2004b). By analogy, KirE might also be
involved in PKS priming.
The Origin of the Kirromycin Pyridone Moiety: Evidence
from Feeding Experiments with 13C-Labeled Precursors
Previous feeding studies on the related antibiotic aurodox did
not reveal the biosynthetic origin of the pyridone group in kirro-
mycin (Liu et al., 1979). In isotope feeding studies on the polyke-
tide, efrotomycin, another member of the elfamycin family, it was
shown that C-4 and C-5 of uracil are efficiently incorporated into
the molecule (Darland et al., 1991). Hence, it was postulated, that
the direct precursor might not be uracil, but rather the degrada-
tion product, b-alanine. While we did not find genes for uracil
degradation in the cluster, the presence of KirD, a putative as-
partate-1-decarboxylase, indicates aspartate as a different
source for this building block in kirromycin biosynthesis.
The enzyme that is supposed to catalyze one of the key steps
of pyridone biosynthesis is the NRPS KirB. Often, the specificity
of these enzymes can be predicted by the analysis of specific
amino acids of their adenylation domains. In the case of KirB,
the signature of the specificity conferring amino acids present
in KirB (DTLQLGVIWK) has not been observed before, so no
good match against known motives described by Stachelhaus
et al. (1999) and Challis et al. (2000) was found. Analysis by the
machine learning-based method of Rausch et al. (2005) pre-
dicted a specificity against small amino acids, like alanine, va-
line, or amino butyric acid.
To test whether b-alanine is required for biosynthesis, feeding
experiments with the kirromycin-producing S. collinus Tu¨ 365
with 13C-labeled putative precursors were performed. [1-13C]ac-
etate and [U-13C3
15N]b-alanine, respectively, were administered
in aqueous solutions during the period of highest production be-
tween the 12th and 24th hour of fermentation. Kirromycin was
isolated from the culture broth, yielding 6–7 mg l1 of the pure
compound, which was subjected to detailed 13C-NMR analysis.
Feeding [1-13C]acetate gave kirromycin with strongly labeled
atoms. The labeling pattern corresponds with the predicted po-
sitions of acetate units as indicated (Table S2): C-24 showed no
significant incorporation, which supports the speculation that
C-24/C-25/N-26 originate from glycine. In contrast to aurodox
biosynthesis (Liu et al., 1979), significant 13C enrichment was de-
tected, especially for the carbonyl C-2 atom of kirromycin from
[1-13C]acetate, which points to time-dependent labeling of the
carboxylic acid pool of the cells during 13C-feeding experiments.
The putative butyrate unit (C-44, C-27), the propionate-derived
C-7 atom, and the presumably b-alanine-derived C-4 atom are
all significantly labeled in kirromycin, but not in aurodox. No
incorporation was found in the methionine-derived carbon
atoms. The 13C-NMR spectrum of labeled kirromycin from
[U-13C3
15N]b-alanine feeding showed complex coupling pat-
terns due to strong 13C-13C and 13C-15N coupling. All acetate182 Chemistry & Biology 15, 175–188, February 2008 ª2008 Elsevieunits were significantly double labeled, the propionate, butyrate,
and glycine units showed labeling according to primary metabo-
lism pathways, but not the methionine-derived atoms. Particu-
larly high incorporation of [U-13C3
15N]b-alanine into the pyridone
ring of kirromycin (C-4/C-5/C-6/N-1) was shown from the 13C-
NMR coupling pattern (Figure 5; Table S2). In addition, HR-
ESI-mass spectrometry allowed for the determination of about
20% 15N enrichment in the presence of additional 13C-enriched
isotopomers (Figure 5). Again, significant 13C incorporation into
the putative pyridone acetate unit (C-2/C-3) was determined
from the coupling pattern in the pyridone ring. This result pro-
vides sound evidence that the pyridone moiety of kirromycin is
built up with b-alanine. Release from KirB and cyclization of
the pyridone ring may be driven by a nucleophilic attack at C-4
that is enabled by keto-enol tautomerism (for details see the
Supplemental Data) as there is no thioesterase domain present
in the cluster.
Precursor Supply
The two genes, kirD and kirN, both have high similarity to genes
involved in primary metabolism. With 68% aa identity (80 % aa
similarity), KirD shows high homology to PanD of Streptomyces
avermitilis. PanD enzymes are aspartate-1-decarboxylases that
are involved in the conversion of aspartate to b-alanine, a precur-
sor of pantothenic acid. There are two putative functions for KirD
in kirromycin biosynthesis. First, KirD may be involved in the ‘‘pri-
mary metabolism’’ function, which is the biosynthesis of phos-
phopantetheine. Phosphopantetheine is part of CoA and an es-
sential cofactor of ACP and PCP domains in PKS and NRPS
enzymes. A second possible role of KirD in antibiotic biosynthe-
sis could be the formation of b-alanine as the last extender unit
for the polyketide chain. So KirD would supply the kirromycin
production machinery with this nonproteinogenic amino acid.
The efficient incorporation of b-alanine into the pyridone group
of kirromycin strongly favors this second function (see above).
KirN has 77% aa identity and 88% aa similarity to the previ-
ously characterized crotonyl-CoA reductase, Ccr, of S. collinus
Tu¨ 1892 (Wallace et al., 1995; Han and Reynolds, 1997). In this
strain, which is different from the kirromycin producer, S. collinus
Tu¨ 365, the reduction of crotonyl-CoA to butyryl-CoA is part of an
anaplerotic pathway that leads to formation of succinyl-CoA.
Studies on aurodox (N-methyl kirromycin) indicate that the ethyl
side chain is derived from butyrate (Liu et al., 1979). From this ev-
idence, we assume that KirN is required to produce sufficient
amounts of the precursor butyryl-CoA, which is subsequently
carboxylated to ethylmalonyl-CoA. Similar enzymes have also
been identified in the gene clusters of tylosin (Gandecha et al.,
1997), concanamycin (Haydock et al., 2005), and other products
that use PKS enzymes to incorporate ethylmalonyl-CoA.
Tailoring, Accessory, and Unknown Functions
After the kirromycin intermediate is released from KirB, some fur-
ther post-PKS/NRPS biosynthetic steps are required to convert
the intermediate into kirromycin.
According to the incorporation pattern of 13C-labeled acetate
and the functional assignment inferred from the analysis of
the genome sequence, the hydroxy groups at C-16 and C-30
are not derived from malonyl-CoA incorporation during PKSr Ltd All rights reserved
Chemistry & Biology
Kirromycin Biosynthesis in S. collinus Tu¨ 365Figure 5. 13C NMR and Isotope Feeding Studies on Kirromycin
(A) Coupling constants from 13C NMR spectra of the kirromycin pyridone fragment (150.8 MHz, CD3OD) after feeding of [U-
13C3
15N]b-alanine. Reference atom: Ø
C-40, C-41, C-42, C-43, C-46, and C-47. Very strong coupling is indicated with an asterisk and very high enrichments by gray shading (Scott et al., 1974). Due to
particularly high enrichment of the b-alanine unit, statistical coupling is observed for C-3/C-4.
(B) 13C-incorporation patterns after feeding of S. collinus Tu¨ 365 with isotope-labeled [1-13C]acetate and [U-13C3
15N]b-alanine.biosynthesis. Besides, tetrahydrofuran formation requires addi-
tional enzymatic steps.
KirOI and KirOII are two putative cytochrome P450-depend-
end hydroxylases encoded in the cluster that may be responsibleChemistry & Biology 15,for these steps. KirOI is highly similar (BLASTP: 44% identity,
59% similarity) to ORF4 of the mitomycin biosynthetic gene clus-
ter of S. lavendulae (Mao et al., 1999). KirOII resembles P450 hy-
droxylases from S. peucetius (Parajuli et al., 2004) and EryF of175–188, February 2008 ª2008 Elsevier Ltd All rights reserved 183
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spora erythraea (Andersen et al., 1993). Future mutational stud-
ies will provide further data to examine whether KirOI and KirOII
are directly involved in the hydroxylations of C-16 and C-30 or
whether they play a role in the formation of the tetrahydrofuran
ring.
KirM is very similar to the O-methyltransferase RapM from the
rapamycin biosynthesis gene cluster of S. hygroscopicus (73%
identity, 85% similarity) (Chung et al., 2001). As there is only
one O-methyl group at C-20, KirM might be involved in its forma-
tion. Unexpectedly, no KR domain is present in module 9, which
would lead to generation of a hydroxy group that is the prerequi-
site for methyl transfer. While the absence of DH domains has
been observed in other trans-AT-type PKS clusters, such as
chivosazol (Perlova et al., 2006), leinamycin (Tang et al., 2004),
or macrolactin (Schneider et al., 2007), the lack of KR domains
has not, to our knowledge, been reported before. Thus, we
have to postulate that the KR activity is provided by an as yet un-
identified enzyme in trans or by an iterative usage of KR domains
of adjacent modules 8 or 10 of the kirromycin PKS.
Six genes are encoded in the cluster, which share similarities
with proteins of unknown function (KirHI–KirHVI). Their specific
roles in the biosynthesis of kirromycin remain unclear. On the
other hand, in the hypothetical biosynthetic pathway, there are
some remaining steps that could not be attributed to any of the
enzymes described above. These steps are (1) dehydrogenation
toward the unsaturated pyridone ring, (2) the formation of C-20-
OCH3, (3) the formation of the intramolecular furan ring, and (4)
the resistance of the producer.
Regulation and Transport
Only two ORFs in the kirromycin biosynthetic gene cluster
encode proteins that are weakly similar to known regulatory pro-
teins. In BLASTP analyses, the KirRI protein (104 aa) shows high-
est similarity to the C terminus of a putative, uncharacterized
TetR family regulator (61% identity, 76% similarity) from Frankia
sp. CcI3. The gene, kirRII, encoding a protein of 119 aa, is lo-
cated directly upstream of kirRI. Its gene product is similar to
the N-terminal half of the same Frankia protein. Whether KirRII
and KirRI, which encode single proteins similar to the C- and
N-terminal portions of different respective TetR repressors,
combine to form a functional entity has yet to be experimentally
proven.
A similar division into two proteins is observed in the KirTI and
KirTII proteins, the genes of which are located directly down-
stream of kirRI. KirTI and KirTII are highly similar to the N- and
C-terminal halves of Frankia sp. CcI3 and S. coelicolor major fa-
cilitator class export proteins. If these proteins are functional,
they may be involved in kirromycin export and self-protection
against the antibiotic.
SIGNIFICANCE
The structural features of kirromycin indicate the involve-
ment of novel biosynthetic pathways. The analysis of the
kirromycin biosynthesis gene cluster fully confirmed this as-
sumption. The polyketide backbone of kirromycin is synthe-
sized by a very unconventional hybrid nonribosomal peptide
synthetase (NRPS)/polyketide synthase (PKS). The compo-184 Chemistry & Biology 15, 175–188, February 2008 ª2008 Elseviesition of these megaenzymes, which is unique among strep-
tomycetes, shows a combination architecture of cis- and
trans-AT-type PKS, variations of classical PKS domain orga-
nization, the occurrence of internal methyltransferase do-
mains, and the presence of PKS domains with as yet un-
known functions.
Predicted by sequence analysis of the gene cluster, the
biosynthetic origin of the pyridone group of kirromycin could
be proven experimentally by isotope feeding/NMR studies.
To our knowledge, no similar pathway to pyridone formation
has been described before on a molecular level.
The elucidation of the kirromycin biosynthesis gene clus-
ter is a prerequisite to understanding the molecular prin-
ciples of the biosynthesis of kirromycin-type antibiotics,
and now enables the use of molecular techniques and/or
combinatorial biosynthesis. It also opens new opportunities
to study the molecular basics of natural product biosynthe-
sis on enzymes that differ from classical PKS I model sys-
tems.
EXPERIMENTAL PROCEDURES
Strain Cultivation and General Methods
S. collinus Tu¨ 365 was obtained from the ‘‘Tu¨binger Stammsammlung’’. For kir-
romycin production, the strain was cultivated in production medium consisting
of soybean flour (10 g l1), mannite (10 g l1), CaCO3 (5 g l
1), and tap water.
The pH was adjusted to 7.3 prior to sterilization. Cultivation for the isolation
of spores was carried out on SFM (Kieser et al., 2000) or HA (malt extract
[10 g l1], yeast extract [4 g l1], glucose [4 g l1], [pH 7.3]) agar. E. coli XL1-
Blue was used as general cloning host for plasmid construction. Luria Bertani
medium, supplemented with the appropriate antibiotics in their recommended
concentrations, was used for E. coli propagation (Sambrook and Russell,
2001).
Methods for isolation and manipulation of DNA were performed as
described by Sambrook and Russell (2001) and Kieser et al. (2000). Plasmid
isolation was carried out with the QIAGEN Plasmid Mini/Midi Kit. DNA from
agarose gels was isolated with QIAGEN QIAquick Kit or Amersham GFX
columns. PCR amplifications were done with Taq DNA polymerase (QIAGEN).
Restriction enzymes were purchased from New England Biolabs, MBI
Fermentas, and Amersham, and used according to the suppliers’ recommen-
dations.
Extraction and Detection of Kirromycin
S. collinus wild-type or mutants were inoculated with a preculture (10%) in 100
ml of production broth and incubated for 3–5 days at 27C/180 rpm in 500 ml
shaking flasks. Culture supernatant was extracted twice with 1 volume ethyl
acetate and concentrated completely in vacuo. The extract was then redis-
solved in appropriate volumes of MeOH (200 ml for 50 ml extraction volume).
Kirromycin production was assayed by TLC with silica gel 60 F254 plates
(Merck), mobile phase: MeOH:CHCl3 (1:10). Kirromycin was detected at wave-
length l = 254 nm and compared to purified substance (provided by H.P. Fie-
dler, Tu¨bingen).
HPLC analyses were performed on an HP1090M/HP3392A/HP7994B sys-
tem (Hewlett Packard) with Nucleosil C18 columns (5 mm, 125 mm 3 4.6
mm) (Grom) with a flow rate of 2 ml min1. The following linear gradient for elu-
tion was applied using solvent PhoA (100% water with 0.1% phosphoric acid)
and solvent AcCN (100% acetonitrile): at 0 min: 100% PhoA; at 15 min:
100%AcCN; at 16 min: PhoA, at 21 min: PhoA. Kirromycin was identified by
comparison with purified substance or by comparison with an HPLC-UV/Vis
spectra library (Fiedler, 1993).
Feeding Experiments, Isolation, and Chemical Analysis
A 150 ml sample of preculture of strain S. collinus Tu¨ 365 (production medium,
rotary shaker [BS4, Braun], 180 rpm, 30C, 48 hr) in 1 l Erlenmeyer flasks (with
three flow spoilers) was used to inoculate a 2 l fermentor vessel (Biostat B,r Ltd All rights reserved
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ditions used were: 48 hr, 400 rpm, 4 vvm aeration, 30C. Feeding experiments
with [1-13C]acetate (Amersham UK) and [13C3-
15N]b-alanine (Chemotrade)
were carried out under conditions described above; precursors were adminis-
tered to the fermentation as sterile aqueous solutions (40 ml). Continuous feed-
ing with a low-rate pump (Ismatec) was carried out between the 12th and 24th
hr of fermentation: Acetate feeding was as follows: [1-13C]acetate (700 mg l1,
8.4 mmol l1 culture broth). b-alanine feeding was as follows: [U-13C3
15N]b-
alanine (250 mg l1, 2.7 mmol l1 culture broth).
The culture broth was separated from the mycelium by filtration. The myce-
lium was discarded and the culture filtrate was extracted three times with equal
amounts of ethyl acetate. The combined organic phases were evaporated to
dryness and yielded the crude extracts (120 mg l1) that were reprecipitated
in ethyl acetate and petroleum ether (1:8) (Bru¨ning, 1996). The precipitate
was applied for gel chromatography on Sephadex LH-20 (100 3 2.5 cm col-
umn, Pharmacia; eluent: methanol). All purification steps were monitored by
TLC (0.25 mm silica gel 60 F254 plates [Merck]; anisaldehyde/sulfuric acid
staining reagent: 1.0 ml of anisaldehyde in 85 ml MeOH, 5 ml of concentrated
sulfuric acid, and 10 ml of acetic acid). The fractions containing kirromycin, as
detected by TLC, were further purified by column chromatography on silica gel
(Merck; CHCl3:MeOH:methanol:25% NH3, 8.0:2.0:0.5), and yielded pure kirro-
mycin (acetate feeding, 6.7 mg; b-alanine feeding, 6.0 mg).
The presence of kirromycin in the extracts and its purity were monitored with
HPLC-MS-DAD analysis (Flux Instruments Rheos 4000, Jasco 851-AS, Finni-
gan Surveyor, and LC-Q system) with a Superspher 100 RP-18endc. column
(4 mm, 100 mm3 2 mm) (Grom) with a flow rate of 0.3 ml min1. The following
linear gradient for elution was applied using solvents A (H2O, 0.05% HCOOH)
and B (MeOH, 0.05% HCOOH): at 0 min, 20% B; at 20 min, 100% B; at 25 min,
100% B; at 27 min, 20% B. Kirromycin was identified via MS ([MH]: 795) and
UV data (lmax = 233 and 322 nm).
1H-NMR and 13C-NMR experiments on kirromycin from standard fermenta-
tions and feeding experiments were recorded in d4-methanol (Varian Inova
600). Chemical shifts are expressed in d values (ppm), with the solvent as in-
ternal reference, to allow for the detection of all signals due to overlapping
or absence of different 13C-NMR signals in other solvents (Barber et al.,
1989). Specific incorporations were calculated according to established pro-
cedures (Scott et al., 1974). 13C-NMR signals from nonlabeled and labeled kir-
romycin were normalized, and the specific incorporation calculated (specific
incorporation = [1.1 3 intensity of unlabeled signal/intensity of labeled signal
 1.1]3 100/enrichment of precursor. The specific incorporation of kirromycin
from the [U-13C3
15N] b-alanine feeding experiment with 15N was determined
by HR-ESI-MS analysis (Bruker FTMS-7 APEX IV 70e FT-ICR spectrometer)
by comparison with MS peaks of natural abundance: the MS peak of single
13C label and single 15N label showed a clear doublet with their respective
intensities.
Generation of a Cosmid Library of S. collinus Tu¨ 365
The genomic library ofS. collinus Tu¨ 365 was generated by using modified pro-
tocols from Beye et al. (1998) and Burgtorf et al. (1998). Homogenized myce-
lium was embedded in 0.5 % low melting point agarose (SeqPlaque GTG, Bio-
zym), treated with 2 mg ml1 lysozyme (Roth) for 14 hr at room temperature
followed by 1 mg ml1 Proteinase K (Merck) treatment for 24 hr at 50C. The
embedded DNA was partially digested with MboI, extracted with Gelase (Epi-
center), and dephosphorylated. The resulting fragments were then ligated into
750 ng of BamHI-digested cosmid vector, pOJ436 (Bierman et al., 1992), de-
salted, packed (Gigapack III Gold Packaging Extract, Stratagene), and trans-
ferred into E. coli DH5a (Stratagene).
Screening of the Cosmid Library
Hybridizing probes were labeled nonradioactively with the Roche DIG PCR la-
beling kit. Primers used for probe labeling were:
(a) KSIIFOR: CTS GGS GAC CCS ATC GAG; ATIREV: GCS GCS GCG ATC
TCS CCC TGS SWG TGS CC. Template DNA was obtained by geno-
mic DNA preparation of S. griseus ssp. sulphurus Tu¨ 1922, S. antibio-
ticus Tu¨ 99, S. galbus Tu¨ 2253, S. hygroscopicus DSM 41530, S. aver-
mitilisDSM 46492,S. collinus Tu¨ 1892. The PCR program was: 94C forChemistry & Biology 15,2 min; 30 cycles of 94C for 1 min, 65C for 1 min, and 72C for 1 min;
and 72C for 5 min in an MJ Research PTC 225 thermocycler.
(b) 1KS50: AGA ATT CGG SCC SGC SCT SAC SGT SGA CAC SGC S;
1rAT30: TTT CTA GAS GCG ATC TCS CCC TGS GWG TGS CC. Tem-
plate DNA was isolated from S. collinus Tu¨ 365. The PCR program was:
94C for 2 min; 30 cycles of 92C for 1 min, 58C for 1 min, 72C for
2 min; 72C for 5 min PCR using a Stratagene RoboCycler 40 Gradient
yielded a 1.5 kb fragment was amplified.
The pooled PCR fragments and the 1.5 kb fragment obtained from the produc-
ing strain were DIG labeled and used as probes to screen the colony filters. Hy-
bridization was performed under standard conditions.
Generation of PKS-Knockout Mutants
Cosmid DNA was isolated and digested with BamHI. Fragments with sizes of
1–4 kb were gel purified and cloned into pK18mob/apra (D. Schwartz, per-
sonal communication), a derivative of pK18mob with an apramycin resis-
tance cassette introduced into the aphII promoter region. The plasmids
were then transferred into S. collinus Tu¨ 365 by intergeneric conjugation
from E. coli ET12567 (Bierman et al., 1992) to the streptomycete. Kirromycin
production was assayed via TLC/HPLC. For nonproducing mutants, correct
integration of the plasmid was tested by PCR amplification of a 0.5 kb inter-
nal fragment of the introduced apramycin resistance gene (primer: apra-up:
AGC TTC TCA ACC TTG G; apra-low: TCC GCC AAG GCA AAG C). The
PCR program was: 94C for 2 min; 30 cycles each of 94C for 1 min, 50C
for 1 min, and 72C for 1 min; and 72C for 5 min on an MJ Research
PTC100 thermocycler. The results of the PCR were confirmed by Southern
hybridization that used the same PCR fragment labeled with Roche PCR-
DIG labeling kit as a probe.
Generation of the orf(+1) Insertion Mutant orf(+1)::pA18
A 1.4 kb internal fragment of orf(+1) was amplified by PCR with the primers 1
dNRPS2-50: AAG GTA CCA ATG CTG GAG GAC TAC G and 1 dNRPS2-30:
AGA AGC TTA GCC GGA GGT GTA GA, and cloned into vector pA18mob
(pK18mob derivative, where aphII was totally replaced by the apramycin re-
sistance cassette) via KpnI and HindIII. This resulted in the plasmid pA18-
orf(+1). Further procedures were identical to the generation of PKS-knockout
mutants.
Generation of a orf(1) Gene Replacement Mutant orf(1)::thio
A 1.5 kb fragment of the flanking regions of orf(1) was PCR amplified using
the primers lorf-1_50: GGA AGC TTG TCG GTG TTG TGC TTG GA/1orf-1_30:
GCT CTA GAC CTG GAA CCA GTG GTA CT and rorf-1_50: AAG GTA CCA
GGA GTA CGC CGA ACA GAG/rorf-1_30: AAG AAT TCC GCG AGT CGA
ATC TGG AG, resulting in the PCR products, lorf(1) and rorf(1). The follow-
ing PCR program was applied in an MJ Research PTC100 thermocycler: 94C
for 2 min; 30 cycles each at 94C for 1:15 min, 60C for 1:30 min, and 72C for
1:30 min; and 72C for 5 min. The thiostrepton resistance cassette was ob-
tained by XbaI/KpnI digestion of pSLE61 (Muth et al., 1988).
All PCR-fragments were individually cloned into the vector pDrive (QIAGEN).
lorf(1) was excised with KpnI and EcoRI, gel purified, and cloned into KpnI/
EcoRI cut pA18. The right fragment was excised from pDrive with HindIII/
XbaI and cloned into pA18 containing the left border fragment. To introduce
the resistance marker, the plasmid containing both fragments was cut KpnI/
XbaI and ligated with the thiostrepton resistance cassette, resulting in the plas-
mid pA18-orf(1)::thio. Transfer to S. collinus wild type was performed as de-
scribed above. Potential mutants were checked by PCR and Southern hybrid-
ization. To promote double crossover events, a stress protocol was applied:
400 ml of a spore suspension (107 cells ml1) of clones carrying pA18-
orf(1)::thio in the genome were treated for 15 min in an ultrasonic bath, sup-
plemented with 1 ml of TSB broth and incubated for 2 hr at 30C. After the in-
cubation, a second ultrasonic treatment (15 min) was applied. Subsequently,
the spores were diluted and spread on HA agar plates containing thiostrepton
(50 mg ml1). Clones where the double crossover had occurred were identified
by replica plating on agar plates with thiostrepton (50 mg ml1) and thiostrep-
ton/apramycin (each 50 mg ml1). Finally, the mutants were checked with PCR
and Southern hybridization.175–188, February 2008 ª2008 Elsevier Ltd All rights reserved 185
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Similar to the generation of the orf(1) inactivation construct, flanking regions
of kirAVI were amplified with the primers lkirAVI-hind-50: ATA AGC TTC GGG
CTC CGC GAT CTG AG/lkirAVI-kpn-30: AAG GTA CCC ACC GCC TCC CAC
GAG GTC and rkirAVI-kpn-50 AAG GTA CCG TGT TCG TGG CCG AGT ACG
G/rkirAVI-eco-30: AAG AAT TCC CAC AGA GCG GTC TCC TTG C, resulting
in PCR products lkirAVI and rkirAVI. The PCR fragments then were cloned
into pDrive (QIAGEN). The thiostrepton resistance cassette was amplified
with the primers thio-kpn-50: AAG GTA CCG GCG AAT ACT TCA TAT GCG
GGG AT/thio-kpn-30: ACG GTA CCT CAC TGA CGA ATC GAG GTC GAG
GA and also cloned into pDrive (QIAGEN) (for PCR program and equipment,
see above).
The left fragment lkirAVI was cloned into pA18 by a HindIII/KpnI restriction/
ligation. Subsequently, the right fragment was inserted via EcoRI/KpnI. Finally,
the thiostrepton resistance cassette was cloned into the KpnI restriction site,
resulting in plasmid pA18-kirAVI::thio. Transfer to S. collinus and generation
and verification of the double crossover mutant was performed as described
above.
Sequencing and Sequence Analysis
Shotgun sequencing of the cosmids was performed by GATC Biotech (Kon-
stanz, Germany). The sequencing raw data were assembled with the software
pipeline phred/phrap/consed (Ewing and Green, 1998; Ewing et al., 1998; Gor-
don et al., 1998). Automatic gene prediction was done with CRITICA (Badger
and Olsen, 1999). Since the automatic gene identification process is error
prone, manual control of the gene prediction was necessary, and was per-
formed with the frame-plot tool provided by the program, ARTEMIS (Ruther-
ford et al., 2000). Homologous sequences were identified with BLAST (Altschul
et al., 1990), and protein motifs were identified with the software, HMMer
(Eddy, 2004), searching the PFam database (Finn et al., 2006). Prediction of
NRPS specificities was performed with the web application, NRPSpredictor,
at http://www-ab.informatik.uni-tuebingen.de/software (Rausch et al., 2005).
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